Potential Determinants of Prescribers' Drug-Drug Interaction Knowledge

Yu Ko, Daniel C. Malone, Jerome V. D'Agostino, Grant H. Skrepnek, Edward P. Armstrong, Mary Brown, Raymond L. Woosley

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Background: Health care professionals' ability to recognize potential drug-drug interactions (potential DDIs) is important in reducing the risk of potential DDIs and their adverse consequences. Until now, little is known about the determinants of prescribers' potential DDI knowledge. Objectives: This study was conducted to develop interval scales to evaluate prescribers' potential DDI knowledge and perceived usefulness of various potential DDI information sources, and to examine demographic and practice factors that may be related to prescribers' knowledge of potential DDIs. Methods: Data were obtained from a national mail survey of prescribers who were determined from pharmacy claims obtained from a pharmacy benefits manager to have prescribed at least 1 drug involved in a potential DDI, and a control group who had prescribed either 1 of the medications in the drug combinations of interest. The survey instrument included 14 drug-drug pairs that evaluated prescribers' ability to recognize clinically important potential DDIs and 5-point Likert scale-type questions that assessed prescribers' perceived usefulness of potential DDI information provided by various sources. The knowledge and usefulness questions were examined via Rasch dichotomous and rating scale models, respectively. Results: A total of 950 completed surveys were included in the analysis (overall adjusted response rate: 7.9%). Rasch analysis of knowledge and usefulness items revealed satisfactory model-data-fit (infit mean square [MNSQ] ≦ 1.5 and outfit MNSQ ≦ 2.0) and moderate person reliability of 0.72 and 0.61, respectively. Multiple regression analysis revealed that compared with generalists, specialists had lower potential DDI knowledge test scores. In addition, poorer potential DDI knowledge was associated with a lack of clinical experience witnessing harm caused by a potential DDI. Also, the prescribers whose drug selections were affected by the risk of potential DDIs "very much" scored higher than those who reported that their prescribing was affected by the risk "a little" or "not at all.". Conclusions: This study found that specialists were less likely to correctly identify interactions compared with generalists. Other important predictors of potential DDI knowledge included the experience of seeing a potential DDI-caused harm and the extent to which the risk of potential DDIs affected prescribers' drug selection.

Original languageEnglish
Pages (from-to)355-366
Number of pages12
JournalResearch in Social and Administrative Pharmacy
Volume4
Issue number4
DOIs
Publication statusPublished - Dec 2008
Externally publishedYes

Fingerprint

Drug interactions
Drug Interactions
Pharmaceutical Preparations

Keywords

  • Adverse drug events
  • Drug-drug interaction
  • Physician knowledge
  • Rasch modeling

ASJC Scopus subject areas

  • Pharmacy
  • Pharmaceutical Science

Cite this

Ko, Y., Malone, D. C., D'Agostino, J. V., Skrepnek, G. H., Armstrong, E. P., Brown, M., & Woosley, R. L. (2008). Potential Determinants of Prescribers' Drug-Drug Interaction Knowledge. Research in Social and Administrative Pharmacy, 4(4), 355-366. https://doi.org/10.1016/j.sapharm.2007.10.004

Potential Determinants of Prescribers' Drug-Drug Interaction Knowledge. / Ko, Yu; Malone, Daniel C.; D'Agostino, Jerome V.; Skrepnek, Grant H.; Armstrong, Edward P.; Brown, Mary; Woosley, Raymond L.

In: Research in Social and Administrative Pharmacy, Vol. 4, No. 4, 12.2008, p. 355-366.

Research output: Contribution to journalArticle

Ko, Y, Malone, DC, D'Agostino, JV, Skrepnek, GH, Armstrong, EP, Brown, M & Woosley, RL 2008, 'Potential Determinants of Prescribers' Drug-Drug Interaction Knowledge', Research in Social and Administrative Pharmacy, vol. 4, no. 4, pp. 355-366. https://doi.org/10.1016/j.sapharm.2007.10.004
Ko, Yu ; Malone, Daniel C. ; D'Agostino, Jerome V. ; Skrepnek, Grant H. ; Armstrong, Edward P. ; Brown, Mary ; Woosley, Raymond L. / Potential Determinants of Prescribers' Drug-Drug Interaction Knowledge. In: Research in Social and Administrative Pharmacy. 2008 ; Vol. 4, No. 4. pp. 355-366.
@article{d06424aa2f6142c49c3ba7104cb2e40b,
title = "Potential Determinants of Prescribers' Drug-Drug Interaction Knowledge",
abstract = "Background: Health care professionals' ability to recognize potential drug-drug interactions (potential DDIs) is important in reducing the risk of potential DDIs and their adverse consequences. Until now, little is known about the determinants of prescribers' potential DDI knowledge. Objectives: This study was conducted to develop interval scales to evaluate prescribers' potential DDI knowledge and perceived usefulness of various potential DDI information sources, and to examine demographic and practice factors that may be related to prescribers' knowledge of potential DDIs. Methods: Data were obtained from a national mail survey of prescribers who were determined from pharmacy claims obtained from a pharmacy benefits manager to have prescribed at least 1 drug involved in a potential DDI, and a control group who had prescribed either 1 of the medications in the drug combinations of interest. The survey instrument included 14 drug-drug pairs that evaluated prescribers' ability to recognize clinically important potential DDIs and 5-point Likert scale-type questions that assessed prescribers' perceived usefulness of potential DDI information provided by various sources. The knowledge and usefulness questions were examined via Rasch dichotomous and rating scale models, respectively. Results: A total of 950 completed surveys were included in the analysis (overall adjusted response rate: 7.9{\%}). Rasch analysis of knowledge and usefulness items revealed satisfactory model-data-fit (infit mean square [MNSQ] ≦ 1.5 and outfit MNSQ ≦ 2.0) and moderate person reliability of 0.72 and 0.61, respectively. Multiple regression analysis revealed that compared with generalists, specialists had lower potential DDI knowledge test scores. In addition, poorer potential DDI knowledge was associated with a lack of clinical experience witnessing harm caused by a potential DDI. Also, the prescribers whose drug selections were affected by the risk of potential DDIs {"}very much{"} scored higher than those who reported that their prescribing was affected by the risk {"}a little{"} or {"}not at all.{"}. Conclusions: This study found that specialists were less likely to correctly identify interactions compared with generalists. Other important predictors of potential DDI knowledge included the experience of seeing a potential DDI-caused harm and the extent to which the risk of potential DDIs affected prescribers' drug selection.",
keywords = "Adverse drug events, Drug-drug interaction, Physician knowledge, Rasch modeling",
author = "Yu Ko and Malone, {Daniel C.} and D'Agostino, {Jerome V.} and Skrepnek, {Grant H.} and Armstrong, {Edward P.} and Mary Brown and Woosley, {Raymond L.}",
year = "2008",
month = "12",
doi = "10.1016/j.sapharm.2007.10.004",
language = "English",
volume = "4",
pages = "355--366",
journal = "Research in Social and Administrative Pharmacy",
issn = "1551-7411",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Potential Determinants of Prescribers' Drug-Drug Interaction Knowledge

AU - Ko, Yu

AU - Malone, Daniel C.

AU - D'Agostino, Jerome V.

AU - Skrepnek, Grant H.

AU - Armstrong, Edward P.

AU - Brown, Mary

AU - Woosley, Raymond L.

PY - 2008/12

Y1 - 2008/12

N2 - Background: Health care professionals' ability to recognize potential drug-drug interactions (potential DDIs) is important in reducing the risk of potential DDIs and their adverse consequences. Until now, little is known about the determinants of prescribers' potential DDI knowledge. Objectives: This study was conducted to develop interval scales to evaluate prescribers' potential DDI knowledge and perceived usefulness of various potential DDI information sources, and to examine demographic and practice factors that may be related to prescribers' knowledge of potential DDIs. Methods: Data were obtained from a national mail survey of prescribers who were determined from pharmacy claims obtained from a pharmacy benefits manager to have prescribed at least 1 drug involved in a potential DDI, and a control group who had prescribed either 1 of the medications in the drug combinations of interest. The survey instrument included 14 drug-drug pairs that evaluated prescribers' ability to recognize clinically important potential DDIs and 5-point Likert scale-type questions that assessed prescribers' perceived usefulness of potential DDI information provided by various sources. The knowledge and usefulness questions were examined via Rasch dichotomous and rating scale models, respectively. Results: A total of 950 completed surveys were included in the analysis (overall adjusted response rate: 7.9%). Rasch analysis of knowledge and usefulness items revealed satisfactory model-data-fit (infit mean square [MNSQ] ≦ 1.5 and outfit MNSQ ≦ 2.0) and moderate person reliability of 0.72 and 0.61, respectively. Multiple regression analysis revealed that compared with generalists, specialists had lower potential DDI knowledge test scores. In addition, poorer potential DDI knowledge was associated with a lack of clinical experience witnessing harm caused by a potential DDI. Also, the prescribers whose drug selections were affected by the risk of potential DDIs "very much" scored higher than those who reported that their prescribing was affected by the risk "a little" or "not at all.". Conclusions: This study found that specialists were less likely to correctly identify interactions compared with generalists. Other important predictors of potential DDI knowledge included the experience of seeing a potential DDI-caused harm and the extent to which the risk of potential DDIs affected prescribers' drug selection.

AB - Background: Health care professionals' ability to recognize potential drug-drug interactions (potential DDIs) is important in reducing the risk of potential DDIs and their adverse consequences. Until now, little is known about the determinants of prescribers' potential DDI knowledge. Objectives: This study was conducted to develop interval scales to evaluate prescribers' potential DDI knowledge and perceived usefulness of various potential DDI information sources, and to examine demographic and practice factors that may be related to prescribers' knowledge of potential DDIs. Methods: Data were obtained from a national mail survey of prescribers who were determined from pharmacy claims obtained from a pharmacy benefits manager to have prescribed at least 1 drug involved in a potential DDI, and a control group who had prescribed either 1 of the medications in the drug combinations of interest. The survey instrument included 14 drug-drug pairs that evaluated prescribers' ability to recognize clinically important potential DDIs and 5-point Likert scale-type questions that assessed prescribers' perceived usefulness of potential DDI information provided by various sources. The knowledge and usefulness questions were examined via Rasch dichotomous and rating scale models, respectively. Results: A total of 950 completed surveys were included in the analysis (overall adjusted response rate: 7.9%). Rasch analysis of knowledge and usefulness items revealed satisfactory model-data-fit (infit mean square [MNSQ] ≦ 1.5 and outfit MNSQ ≦ 2.0) and moderate person reliability of 0.72 and 0.61, respectively. Multiple regression analysis revealed that compared with generalists, specialists had lower potential DDI knowledge test scores. In addition, poorer potential DDI knowledge was associated with a lack of clinical experience witnessing harm caused by a potential DDI. Also, the prescribers whose drug selections were affected by the risk of potential DDIs "very much" scored higher than those who reported that their prescribing was affected by the risk "a little" or "not at all.". Conclusions: This study found that specialists were less likely to correctly identify interactions compared with generalists. Other important predictors of potential DDI knowledge included the experience of seeing a potential DDI-caused harm and the extent to which the risk of potential DDIs affected prescribers' drug selection.

KW - Adverse drug events

KW - Drug-drug interaction

KW - Physician knowledge

KW - Rasch modeling

UR - http://www.scopus.com/inward/record.url?scp=57049099172&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=57049099172&partnerID=8YFLogxK

U2 - 10.1016/j.sapharm.2007.10.004

DO - 10.1016/j.sapharm.2007.10.004

M3 - Article

C2 - 19064242

AN - SCOPUS:57049099172

VL - 4

SP - 355

EP - 366

JO - Research in Social and Administrative Pharmacy

JF - Research in Social and Administrative Pharmacy

SN - 1551-7411

IS - 4

ER -